| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_KLHL2_0000100 | Exon-Exon | chr4:166131171-166184511 | chr4:165210019-165263359 | 680 nt | 0.4368 |
| hsa_KLHL2_0000200 | Exon-Exon | chr4:166131171-166220808 | chr4:165210019-165299656 | 1057 nt | 0.4352 |
| hsa_KLHL2_0001200 | Exon-Exon | chr4:166141086-166150065 | chr4:165219934-165228913 | 233 nt | 0.4206 |
| hsa_KLHL2_0001300 | Exon-Exon | chr4:166141086-166160051 | chr4:165219934-165238899 | 355 nt | 0.4169 |
| hsa_KLHL2_0001400 | Exon-Exon | chr4:166141086-166184511 | chr4:165219934-165263359 | 518 nt | 0.4344 |
| hsa_KLHL2_0001500 | Exon-Exon | chr4:166141086-166215620 | chr4:165219934-165294468 | 628 nt | 0.4236 |
| hsa_KLHL2_0001600 | Exon-Exon | chr4:166141086-166226877 | chr4:165219934-165305725 | 1013 nt | 0.4452 |
| hsa_KLHL2_0001700 | Exon-Exon | chr4:166141086-166235318 | chr4:165219934-165314166 | 1583 nt | 0.4479 |
| hsa_KLHL2_0001800 | Exon-Exon | chr4:166141086-166239121 | chr4:165219934-165317969 | 1727 nt | 0.4459 |
| hsa_KLHL2_0002200 | Exon-Exon | chr4:166149959-166150065 | chr4:165228807-165228913 | 107 nt | 0.4393 |
A study in humans identified the circKLHL2 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically characterized [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in mice and human patients demonstrated that the circKLHL2 may expedite sepsis-induced acute lung injury by adjusting the miR-29b-3p/ROCK axis [Xu et al. DOI:10.1080/01902148.2024.2429184].